Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGB-10 Phase 3 similarity study vs Forteo in high-fracture-risk osteoporosis
jRCT2080223153Phase 3
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of Terossa in involutional osteoporosis (2 arms), sponsored by Mochida Pharmaceutical Co., Ltd.
02
Drugs
Terossa
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCT2080223153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223153.